Cormorant Asset Management, LP sold $9.8M of DRUG
other at BRIGHT MINDS BIOSCIENCES INC.. 109,331 shares at an average of $89.50, traded Apr 28, 2026, filed Apr 30, 2026.
Score components
- +8RoleOther
- +25Trade size$9.8M at market
- +5Share of holdings soldSold 10% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +0.1%, 3m -15.1%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000929638-26-001708, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | SOpen-market sale Common Sharesindirect: See Footnotes | -109,331 | $89.50 | $9.8M | 950,000 | Apr 30, 2026 |
Related signals
Other insiders at BRIGHT MINDS BIOSCIENCES INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | DRUGbuy BRIGHT MINDS BIOSCIENCES INC. | Cormorant Asset Management, LP owner | $4.0M 184,331 shares | +21% | |
| 42Moderate | DRUGbuy BRIGHT MINDS BIOSCIENCES INC. | Cormorant Asset Management, LP owner | $3.2M 422,591 shares | +93% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.